Curcumin analog, GO-Y078, induces HO-1 transactivation-mediated apoptotic cell death of oral cancer cells by triggering MAPK pathways and AP-1 DNA-binding activity

References

• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–386.
   PubMed Web of Science ®Google Scholar
• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.
   PubMed Web of Science ®Google Scholar
• Specenier PM, Vermorken JB. Current concepts for the management of head and neck cancer: chemotherapy. Oral Oncol. 2009;45(4–5):409–415.
   PubMedGoogle Scholar
• Ghani WMN, Ramanathan A, Prime SS, et al. Survival of oral cancer patients in different ethnicities. Cancer Invest. 2019;37(7):275–287.
   PubMed Web of Science ®Google Scholar
• Zhang QY, Wang FX, Jia KK, et al. Natural product interventions for chemotherapy and radiotherapy-induced side effects. Front Pharmacol. 2018;9:1253.
   PubMed Web of Science ®Google Scholar
• Verhagen AM, Ekert PG, Pakusch M, et al. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell. 2000;102(1):43–53.
   PubMed Web of Science ®Google Scholar
• Endo K, Kohnoe S, Watanabe A, et al. Clinical significance of smac/DIABLO expression in colorectal cancer. Oncol Rep. 2009;21(2):351–355.
   PubMedGoogle Scholar
• Bao ST, Gui SQ, Lin MS. Relationship between expression of smac and survivin and apoptosis of primary hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2006;5(4):580–583.
   PubMedGoogle Scholar
• Sekimura A, Konishi A, Mizuno K, et al. Expression of smac/DIABLO is a novel prognostic marker in lung cancer. Oncol Rep. 2004;11(4):797–802.
   PubMedGoogle Scholar
• Mizutani Y, Katsuoka Y, Bonavida B. Low circulating serum levels of second mitochondria-derived activator of caspase (smac/DIABLO) in patients with bladder cancer. Int J Oncol. 2012;40(4):1246–1250.
   PubMedGoogle Scholar
• Mizutani Y, Nakanishi H, Yamamoto K, et al. Downregulation of smac/DIABLO expression in renal cell carcinoma and its prognostic significance. J Clin Oncol. 2005;23(3):448–454.
   PubMed Web of Science ®Google Scholar
• Liang W, Liao Y, Zhang J, et al. Heat shock factor 1 inhibits the mitochondrial apoptosis pathway by regulating second mitochondria-derived activator of caspase to promote pancreatic tumorigenesis. J Exp Clin Cancer Res. 2017;36(1):64.
   PubMedGoogle Scholar
• Sun Q, Zheng X, Zhang L, et al. Smac modulates chemosensitivity in head and neck cancer cells through the mitochondrial apoptotic pathway. Clin Cancer Res. 2011;17(8):2361–2372.
   PubMedGoogle Scholar
• Yang L, Kumar B, Shen C, et al. LCL161, a SMAC-mimetic, preferentially radiosensitizes human papillomavirus-negative head and neck squamous cell carcinoma. Mol Cancer Ther. 2019;18(6):1025–1035.
   PubMedGoogle Scholar
• Yang J, McEachern D, Li W, et al. Radiosensitization of head and neck squamous cell carcinoma by a SMAC-mimetic compound, SM-164, requires activation of caspases. Mol Cancer Ther. 2011;10(4):658–669.
   PubMedGoogle Scholar
• Tenhunen R, Marver HS, Schmid R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci U S A. 1968;61(2):748–755.
   PubMed Web of Science ®Google Scholar
• Mayerhofer M, Florian S, Krauth MT, et al. Identification of heme oxygenase-1 as a novel BCR/ABL-dependent survival factor in chronic myeloid leukemia. Cancer Res. 2004;64(9):3148–3154.
   PubMed Web of Science ®Google Scholar
• Ren QG, Yang SL, Li PD, et al. Low heme oxygenase-1 expression promotes gastric cancer cell apoptosis, inhibits proliferation and invasion, and correlates with increased overall survival in gastric cancer patients. Oncol Rep. 2017;38(5):2852–2858.
   PubMedGoogle Scholar
• Was H, Cichon T, Smolarczyk R, et al. Overexpression of heme oxygenase-1 in murine melanoma: increased proliferation and viability of tumor cells, decreased survival of mice. Am J Pathol. 2006;169(6):2181–2198.
   PubMedGoogle Scholar
• Nuhn P, Künzli BM, Hennig R, et al. Heme oxygenase-1 and its metabolites affect pancreatic tumor growth in vivo. Mol Cancer. 2009;8(1):37.
   PubMedGoogle Scholar
• Gueron G, De Siervi A, Ferrando M, et al. Critical role of endogenous heme oxygenase 1 as a tuner of the invasive potential of prostate cancer cells. Mol Cancer Res. 2009;7(11):1745–1755.
   PubMedGoogle Scholar
• Wegiel B, Gallo D, Csizmadia E, et al. Carbon monoxide expedites metabolic exhaustion to inhibit tumor growth. Cancer Res. 2013;73(23):7009–7021.
   PubMed Web of Science ®Google Scholar
• Hill M, Pereira V, Chauveau C, et al. Heme oxygenase-1 inhibits rat and human breast cancer cell proliferation: mutual cross inhibition with indoleamine 2,3-dioxygenase. Faseb J. 2005;19(14):1957–1968.
   PubMedGoogle Scholar
• Lin CW, Shen SC, Hou WC, et al. Heme oxygenase-1 inhibits breast cancer invasion via suppressing the expression of matrix metalloproteinase-9. Mol Cancer Ther. 2008;7(5):1195–1206.
   PubMed Web of Science ®Google Scholar
• Wu MS, Chien CC, Chang J, et al. Pro-apoptotic effect of haem oxygenase-1 in human colorectal carcinoma cells via endoplasmic reticular stress. J Cell Mol Med. 2019;23(8):5692–5704.
   PubMedGoogle Scholar
• Zou C, Zou C, Cheng W, et al. Heme oxygenase-1 retards hepatocellular carcinoma progression through the microRNA pathway. Oncol Rep. 2016;36(5):2715–2722.
   PubMedGoogle Scholar
• Skrzypek K, Tertil M, Golda S, et al. Interplay between heme oxygenase-1 and miR-378 affects non-small cell lung carcinoma growth, vascularization, and metastasis. Antioxid Redox Signal. 2013;19(7):644–660.
   PubMedGoogle Scholar
• Hsieh MJ, Lin CC, Lo YS, et al. Chrysosplenol d triggers apoptosis through heme oxygenase-1 and mitogen-activated protein kinase signaling in oral squamous cell carcinoma. Cancers (Basel). 2021;13(17):4327.
   PubMedGoogle Scholar
• Yanagawa T, Omura K, Harada H, et al. Heme oxygenase-1 expression predicts cervical lymph node metastasis of tongue squamous cell carcinomas. Oral Oncol. 2004;40(1):21–27.
   PubMedGoogle Scholar
• Imran M, Ullah A, Saeed F, et al. Cucurmin, anticancer, & antitumor perspectives: a comprehensive review. Crit Rev Food Sci Nutr. 2018;58(8):1271–1293.
   PubMed Web of Science ®Google Scholar
• Sivanantham B, Sethuraman S, Krishnan UM. Combinatorial effects of curcumin with an anti-neoplastic agent on head and neck squamous cell carcinoma through the regulation of egfr-erk1/2 and apoptotic signaling pathways. ACS Comb Sci. 2016;18(1):22–35.
   PubMedGoogle Scholar
• Ireson CR, Jones DJ, Orr S, et al. Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiol Biomarkers Prev. 2002;11(1):105–111.
   PubMed Web of Science ®Google Scholar
• Kudo C, Yamakoshi H, Sato A, et al. Synthesis of 86 species of 1,5-diaryl-3-oxo-1,4-pentadienes analogs of curcumin can yield a good lead in vivo. BMC Pharmacol. 2011;11(1):4.
   PubMedGoogle Scholar
• Murakami M, Ohnuma S, Fukuda M, et al. Synthetic analogs of curcumin modulate the function of multidrug resistance-linked ATP-binding cassette transporter ABCG2. Drug Metab Dispos. 2017;45(11):1166–1177.
   PubMed Web of Science ®Google Scholar
• Kudo C, Yamakoshi H, Sato A, et al. Novel curcumin analogs, GO-Y030 and GO-Y078, are multi-targeted agents with enhanced abilities for multiple myeloma. Anticancer Res. 2011;31(11):3719–3726.
   PubMedGoogle Scholar
• Lin CW, Yang WE, Lee WJ, et al. Lipocalin 2 prevents oral cancer metastasis through carbonic anhydrase IX inhibition and is associated with favourable prognosis. Carcinogenesis. 2016;37(7):712–722.
   PubMedGoogle Scholar
• Chien MH, Lee WJ, Yang YC, et al. N-α-acetyltransferase 10 protein promotes metastasis by stabilizing matrix metalloproteinase-2 protein in human osteosarcomas. Cancer Lett. 2018;433:86–98.
   PubMedGoogle Scholar
• Hatamipour M, Ramezani M, Tabassi SAS, et al. Demethoxycurcumin: a naturally occurring curcumin analogue with antitumor properties. J Cell Physiol. 2018;233(12):9247–9260.
   PubMedGoogle Scholar
• Scheurer MJJ, Seher A, Steinacker V, et al. Targeting inhibitors of apoptosis in oral squamous cell carcinoma in vitro. J Craniomaxillofac Surg. 2019;47(10):1589–1599.
   PubMedGoogle Scholar
• Funes SC, Rios M, Fernández-Fierro A, et al. Naturally derived heme-oxygenase 1 inducers and their therapeutic application to immune-mediated diseases. Front Immunol. 2020;11:1467.
   PubMed Web of Science ®Google Scholar
• Zhen L, Fan D, Yi X, et al. Curcumin inhibits oral squamous cell carcinoma proliferation and invasion via EGFR signaling pathways. Int J Clin Exp Pathol. 2014;7(10):6438–6446.
   PubMed Web of Science ®Google Scholar
• Giordano A, Tommonaro G. Curcumin and cancer. Nutrients. 2019;11(10):2376.
   PubMed Web of Science ®Google Scholar
• Nitti M, Piras S, Marinari UM, et al. HO-1 induction in cancer progression: a matter of cell adaptation. Antioxidants (Basel). 2017;6(2). DOI:https://doi.org/10.3390/antiox6020029
   PubMedGoogle Scholar
• Chiang SK, Chen SE, Chang LC. A dual role of heme oxygenase-1 in cancer cells. Int J Mol Sci. 2018;20(1):39.
   PubMed Web of Science ®Google Scholar
• Lee WY, Chen YC, Shih CM, et al. The induction of heme oxygenase-1 suppresses heat shock protein 90 and the proliferation of human breast cancer cells through its byproduct carbon monoxide. Toxicol Appl Pharmacol. 2014;274(1):55–62.
   PubMedGoogle Scholar
• Saffari-Chaleshtori J, Heidarian E, Shafiee SM. apoptotic effects of bilirubin on skin cancer cell lines sk-mel-3 (melanoma) and a431 (non-melanoma). Anticancer Agents Med Chem. 2021;21(14):1871–1882.
   PubMedGoogle Scholar
• Ollinger R, Kogler P, Troppmair J, et al. Bilirubin inhibits tumor cell growth via activation of ERK. Cell Cycle. 2007;6(24):3078–3085.
   PubMed Web of Science ®Google Scholar
• Papanikolaou G, Pantopoulos K. Iron metabolism and toxicity. Toxicol Appl Pharmacol. 2005;202(2):199–211.
   PubMed Web of Science ®Google Scholar
• Li Z, Chen L, Chen C, et al. Targeting ferroptosis in breast cancer. Biomark Res. 2020;8(1):58.
   PubMed Web of Science ®Google Scholar
• Chang LC, Chiang SK, Chen SE, et al. Heme oxygenase-1 mediates BAY 11-7085 induced ferroptosis. Cancer Lett. 2018;416:124–137.
   PubMed Web of Science ®Google Scholar
• Li R, Zhang J, Zhou Y, et al. Transcriptome investigation and in vitro verification of curcumin-induced ho-1 as a feature of ferroptosis in breast cancer cells. Oxid Med Cell Longev. 2020;2020:3469840.
   PubMedGoogle Scholar
• Hong SH, Lee DH, Lee YS, et al. Molecular crosstalk between ferroptosis and apoptosis: emerging role of ER stress-induced p53-independent PUMA expression. Oncotarget. 2017;8(70):115164–115178.
   PubMedGoogle Scholar
• Kiemer AK, Bildner N, Weber NC, et al. Characterization of heme oxygenase 1 (heat shock protein 32) induction by atrial natriuretic peptide in human endothelial cells. Endocrinology. 2003;144(3):802–812.
   PubMedGoogle Scholar
• Lee YJ, Beak SY, Choi I, et al. Quercetin and its metabolites protect hepatocytes against ethanol-induced oxidative stress by activation of nrf2 and AP-1. Food Sci Biotechnol. 2018;27(3):809–817.
   PubMedGoogle Scholar
• Balogun E, Hoque M, Gong P, et al. Curcumin activates the haem oxygenase-1 gene via regulation of nrf2 and the antioxidant-responsive element. Biochem J. 2003;371(3):887–895.
   PubMedGoogle Scholar
• Bao J, Ding R, Zou L, et al. Forsythiae fructus inhibits b16 melanoma growth involving mapks/nrf2/ho-1 mediated anti-oxidation and anti-inflammation. Am J Chin Med. 2016;44(5):1043–1061.
   PubMed Web of Science ®Google Scholar
• Yang CM, Huang SM, Liu CL, et al. Apo-8’-lycopenal induces expression of HO-1 and NQO-1 via the ERK/p38-nrf2-are pathway in human hepg2 cells. J Agric Food Chem. 2012;60(6):1576–1585.
   PubMedGoogle Scholar
• McNally SJ, Harrison EM, Ross JA, et al. Curcumin induces heme oxygenase 1 through generation of reactive oxygen species, p38 activation and phosphatase inhibition. Int J Mol Med. 2007;19(1):165–172.
   PubMed Web of Science ®Google Scholar
• Humar M, Loop T, Schmidt R, et al. The mitogen-activated protein kinase p38 regulates activator protein 1 by direct phosphorylation of c-Jun. Int J Biochem Cell Biol. 2007;39(12):2278–2288.
   PubMed Web of Science ®Google Scholar
• Papachristou DJ, Batistatou A, Sykiotis GP, et al. Activation of the JNK-AP-1 signal transduction pathway is associated with pathogenesis and progression of human osteosarcomas. Bone. 2003;32(4):364–371.
   PubMedGoogle Scholar
• Bellezza I, Tucci A, Galli F, et al. Inhibition of NF-κB nuclear translocation via HO-1 activation underlies α-tocopheryl succinate toxicity. J Nutr Biochem. 2012;23(12):1583–1591.
   PubMed Web of Science ®Google Scholar
• Martinez-Ruiz G, Maldonado V, Ceballos-Cancino G, et al. Role of smac/DIABLO in cancer progression. J Exp Clin Cancer Res. 2008;27(1):48.
   PubMedGoogle Scholar
• Zhao XY, Wang XY, Wei QY, et al. Potency and selectivity of SMAC/diablo mimetics in solid tumor therapy. Cells. 2020;9(4):1012.
   PubMed Web of Science ®Google Scholar